Indiana Biosciences Research Institute

At a Glance
  • Status: Active Consortium
  • Year Launched: 2013
  • Initiating Organization: Indiana State University
  • Initiator Type: Academia
  • No disease focus
  • Location: North America


Indiana’s life sciences landscape represents global and local enterprises that are developing next-generation drugs and pharmaceuticals, novel and companion diagnostics tests, cell-based therapies, medical devices and equipment, agricultural biotechnology and crop protection products, and animal health and production solutions. This ecosystem is the foundation for the Indiana Biosciences Research Institute. The Institute is purposefully designed to advance research in today’s and tomorrow’s new research paradigm, where interdisciplinary teams of scientists representing biomedical engineering, nanotechnology, and other high-tech disciplines are necessary to capture discoveries and help speed the process from development to market. As the research and discovery process continues to expand its reach globally, the Indiana Biosciences Research Institute will attract the best scientific minds from around the world to Indiana, creating a research hub that will commercialize innovations, strengthen Indiana’s economy, and develop answers to some of the most pressing human health issues.


The mission is to foster collaborative—not competitive—industry-led research.

Structure & Governance

The estimated $360 million Indiana Biosciences Research Institute is a nonprofit entity that is anticipated to be supported largely by corporate and philanthropic funding with oversight from a largely donor-based board of directors representing the life sciences industry, the state of Indiana, academia, and nonprofit donors.

The Institute will attract local and national scientific leaders beginning with the CEO and research “Indiana Fellows.” These research fellows will lead teams of scientists and partner with industry and universities on research projects. These teams will consist of experts across a spectrum of competencies, including bioengineering, bioinformatics, nanotechnology, and agriculture. These cross-functional teams will share resources and research laboratories at the Indiana Biosciences Research Institute and will work onsite at industry and research university labs with academic and industry scientists.

Board of Directors:
David Johnson, president and CEO, BioCrossroads
Darren J. Carroll, vice president, corporate business development, Eli Lilly and Company
D. Ry Wagner, global new ventures and technology leader, Dow AgroSciences LLC
Jon Serbousek, president, Biomet Biologics
Dan Peterson, vice president, industry and government affairs, Cook Inc.
Wayne Burris, senior vice president and CFO, Roche Diagnostics
Daniel Evans, president and CEO, Indiana University Health
Bill Stephan, vice president for engagement, Indiana University
Ryan Streeter, senior economic policy director, Office of Indiana Governor Mike Pence


The Indiana Biosciences Research Institute is industry-driven, meaning industry is a key driver of its funding and will play a key role in defining the research agenda with university partners to optimize commercialization opportunities.

The State of Indiana has appropriated $25 million for the biennium for start-up costs. Industry and philanthropic funders have contributed an additional $25 million in start-up funding. This $50 million in funding will be used in part to recruit a nationally recognized CEO and research fellows, and it is the first step in a larger capital campaign that will raise funds to support the Institute's mission and the activities of the Indiana Fellows. The annual operating budget, which is anticipated to be more than $30 million annually, will be supported by industry-sponsored research, federally funded research, and proceeds from the Institute’s endowment.


Economic Impact:
More than a decade ago, Indiana leaders identified life sciences as a key industry cluster that could support significant economic growth. Today, Indiana is among the top five states in the country in terms of total life sciences jobs and companies. Indiana also has a substantial number and diversity of life sciences companies that include global industry leaders and smaller, entrepreneurial enterprises.

Points of Contact

300 N. Meridian Street
Suite 950
Indianapolis, IN 46204
phone: 317-238-2450

Troy Hege, Project Director
phone: 317-238-2460

Sponsors & Partners


Biomet Orthopedics, Inc.

Cook Group, Inc.

Dow AgroSciences LLC

Eli Lilly and Co.

Indiana University

Indiana University Health

Purdue University

Roche Diagnostics

The State of Indiana

The University of Notre Dame

Last Updated: 04/15/2016

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.